News & Media
Nov 28 / 2024
Hemostemix ANNOUNCES $2,675,981 Private Placement including second tranche of $833,258
Hemostemix ANNOUNCES $2,675,981 Private Placement including second tranche of $833,258
Nov 25 / 2024
Hemostemix ANNOUNCES ACP-01 Treatment-Purchase available with Social Media campaign underway
Hemostemix ANNOUNCES ACP-01 Treatment-Purchase available with Social Media campaign underway
Oct 31 / 2024
Hemostemix ANNOUNCES the first tranche closing of $1.8M of its recently announced Private Placement
Hemostemix ANNOUNCES the first tranche closing of $1.8M of its recently announced Private Placement
Aug 01 / 2024
Hemostemix Closes its Funded Manufacturing Services Agreement with CytoImmune, Restarting Production of ACP-01
Hemostemix Closes its Funded Manufacturing Services Agreement with CytoImmune, Restarting Production of ACP-01
Jun 03 / 2024
Hemostemix Announces Strategic Manufacturing Partnership with CytoImmune Therapeutics and $1,800,000 in Financing Commitments
Hemostemix Announces Strategic Manufacturing Partnership with CytoImmune Therapeutics and $1,800,000 in Financing Commitments
Aug 29 / 2023
Hemostemix Announces the Incorporation of Hemostemix Quebec Inc. and $6 Million in Grant Applications
Hemostemix Announces the Incorporation of Hemostemix Quebec Inc. and $6 Million in Grant Applications
May 02 / 2023
Hemostemix (PreCerv Inc.) Retains Chris McNorgan PhD to License NCP-01 to Neural Electrode Brain Implant Company
Hemostemix (PreCerv Inc.) Retains Chris McNorgan PhD to License NCP-01 to Neural Electrode Brain Implant Company
Jan 23 / 2023
Hemostemix Hiring 4 New Biotechnologists in Montreal and Applying for Grants to Fund up to 75% of 5-Year Costs
Hemostemix Hiring 4 New Biotechnologists in Montreal and Applying for Grants to Fund up to 75% of 5-Year Costs
Oct 26 / 2022
Hemostemix Announces Dr. Giannetti and Dr. Cecere as Co-Lead Medical Consultants, Cardiovascular Clinical Trials
Hemostemix Announces Dr. Giannetti and Dr. Cecere as Co-Lead Medical Consultants, Cardiovascular Clinical Trials
Sep 27 / 2022
Hemostemix Announces the Appointment of Dr. Ernst von Schwarz, MD, PhD, FESC, FACC, FSCAI to its Scientific Advisory Board
Hemostemix Announces the Appointment of Dr. Ernst von Schwarz, MD, PhD, FESC, FACC, FSCAI to its Scientific Advisory Board
Sep 20 / 2022
Hemostemix Announces the Appointment of Dr. Terry Hébert, PhD, to its Scientific Advisory Board
Hemostemix Announces the Appointment of Dr. Terry Hébert, PhD, to its Scientific Advisory Board
Sep 16 / 2022
Hemostemix Announces the Appointment of Dr. Nadia Giannetti, MD, to its Scientific Advisory Board
Hemostemix Announces the Appointment of Dr. Nadia Giannetti, MD, to its Scientific Advisory Board
Sep 15 / 2022
Hemostemix Announces the Appointment of Dr. Johannes Grillari to its Scientific Advisory Board
Hemostemix Announces the Appointment of Dr. Johannes Grillari to its Scientific Advisory Board